Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Chondrogenesis just ain’t what it used to be
Gerard Karsenty
Gerard Karsenty
Published February 15, 2001
Citation Information: J Clin Invest. 2001;107(4):405-407. https://doi.org/10.1172/JCI12294.
View: Text | PDF
Commentary

Chondrogenesis just ain’t what it used to be

  • Text
  • PDF
Abstract

Authors

Gerard Karsenty

×

Figure 1

Options: View larger image (or click on image) Download as PowerPoint
Molecular control of endochondral ossification. Transcription factors (C...
Molecular control of endochondral ossification. Transcription factors (Cbfa1 and others) promote the differentiation of the type II collagen–producing cells present in the skeletal mesenchymal condensations into Ihh-secreting hypertrophic chondrocytes. Ihh then acts both on the cells of the perichondrium and on the cells of the bone collar. In the perichondrium, Ihh favors the production of PTHrP, which in turn inhibits chondrocyte hypertrophy. In the bone collar, Ihh induces the expression of Cbfa1, which triggers the osteoblastic differentiation of these cells. Hypertrophic chondrocytes also secrete VEGF, which promotes vascular invasion of the skeletal structure. Blood vessels reach the hypertrophic area, chondroclast/osteoclasts and resorb the ossified cartilaginous matrix. Osteoblasts derived from the bone collar replace this matrix with a bone matrix rich in type I collagen.

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts